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Abstract ASD research is at an important crossroads. The
ASD diagnosis is important for assigning a child to early be-
havioral intervention and explaining a child’s condition. But
ASD research has not provided a diagnosis-specific medical
treatment, or a consistent early predictor, or a unified life
course. If the ASD diagnosis also lacks biological and con-
struct validity, a shift away from studying ASD-defined sam-
ples would be warranted. Consequently, this paper reviews
recent findings for the neurobiological validity of ASD, the
construct validity of ASD diagnostic criteria, and the construct
validity of ASD spectrum features. The findings reviewed
indicate that the ASD diagnosis lacks biological and construct
validity. The paper concludes with proposals for research go-
ing forward.
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The goal of the DSM-3 nosology (American Psychiatric
Association 1980) was to create reliable and standard categor-
ical psychiatric diagnoses (Robins and Guze 1970). However,
in the past 30 years, clinical, genetics, and neuroscience find-
ings have revealed that the DSM diagnoses are not biological-
ly valid. The National Institutes of Mental Health (NIMH)
responded by proposing the Research Domain Criteria
(RDoC) framework for a brain-based transdiagnostic psychi-
atric symptom nosology (Cuthbert and Insel 2013; Insel et al.
2010; Lilienfeld and Treadway 2016). Peterson (2015) and
Weinberger et al. (2015) argued that the RDoC could not
replace the DSM-5 psychiatric nosology (American
Psychiatric Association 2013) or the parallel International
Classification of Diseases (ICD) psychiatric nosology
(World Health Organization 2012). But BFor the foreseeable
future, RDoC is not envisioned as a system of psychiatric
classification in its own right. Instead, in the near term,
RDoC and DSM-ICD are expected to coexist. Nevertheless,
RDoC is intended to provide scaffolding for a large-scale re-
search program that will ultimately yield an alternative to
DSM-ICD^ (Lilienfeld and Treadway 2016, p. 445).
RDoC advocates accept that DSM-5/ICD psychiatric cate-
gories remain necessary in clinical practice, but argue that
researchers should shift to RDoC study designs immediately.
They assert that studying psychiatric categories lacking bio-
logical validity blocks the discovery of brain bases for psy-
chopathology and thus cannot lead to effective medical treat-
ments for specific psychiatric symptoms (Cuthbert and Insel
2013; Insel et al. 2010; Lilienfeld and Treadway 2016; Yee
et al. 2015). Against this RDoC imperative for biological va-
lidity, Weinberger et al. (2015) countered that current DSM-5
psychiatric behavioral diagnoses were valid when they
yielded effective medical treatment, clear prognosis, and a life
course specific to a diagnosis.
Autism spectrum disorder (ASD) research has been produc-
tive (Dawson 2016; de la Torre-Ubieta et al. 2016; Szatmari
et al. 2016), but no ASD research findings have met the validity
criteria of Weinberger et al. (2015). DSM-5 ASD research has
found no specific effective pharmacotherapy or other medical
treatment (Na Young and Findling 2015). The only broadly
successful ASD treatment has been early behavioral intervention
* Lynn Waterhouse
lynwater@tcnj.edu
1 The College of New Jersey, Ewing, NJ, USA
2 Autism Treatment Research Laboratory, New York State Institute for
Basic Research in Developmental Disabilities, Staten Island, NY,
USA
3 University of Gothenburg, Gothenburg, Sweden
Rev J Autism Dev Disord (2016) 3:302–329
DOI 10.1007/s40489-016-0085-x
programs (Kasari 2015; Schreibman et al. 2015; Smith and
Iadarola 2015; Volkmar et al. 2014), but these treatments are
not unique to ASD (Losinski et al. 2014), and the long-term
effectiveness of these programs is not yet known (Fernell et al.
2011, 2014). Researchers who studied infant siblings of children
with ASD concluded no single early behavior could predict
ASD diagnoses (Zwaigenbaum et al. 2015), and ASD has been
found with widely varied trajectories of development (Fountain
et al. 2012; Lord et al. 2015) and varied life outcomes (Fein et al.
2013; Helles et al. 2015; Steinhausen et al. 2016).
ASD research is at a crucial decision point. The ASD di-
agnosis remains necessary in the clinic to assign a child to
early behavioral intervention and to explain a child’s condi-
tion. But researchers must decide whether to continue study-
ing ASD-defined samples or not. Given that ASD lacks any
diagnosis-specific medical treatment, any consistent early pre-
dictor, or any specific life course, if the ASD diagnosis also
lacks biological and construct validity, a shift away from
studying ASD-defined samples would be warranted.
Consequently, this paper reviews recent findings for ASD
biological and construct validity. This paper is not a meta-
analysis; instead it brings together competing and unresolved
findings. The first section examines evidence for the neurobiolo-
gical validity of ASD. The second section outlines evidence for
the construct validity of ASD diagnostic criteria. The third section
explores evidence for the construct validity of ASD spectrum
features beyond ASD diagnostic symptoms. The paper concludes
that the evidence reviewed does not provide support for the
neurobiological or construct validity of the ASD diagnosis, and
therefore the ASD diagnosis should be disbanded in research.
Does ASD Have Neurobiological Validity?
TheASD diagnosis would be biologically valid if all or nearly all
individuals diagnosed with ASD shared one or a few related
brain impairments. Researchers have tried different means to find
a unitary ASD brain impairment. Researchers have measured the
brain structures of idiopathic ASD, defined as having no known
genetic or environmental cause. Researchers have proposed and
tested models of unitary ASD brain impairment. Researchers
have sought brain impairments unique to each core ASD diag-
nostic symptom. Researchers have looked for an independent
ASD brain impairment in syndromic ASD, defined as occurring
with known genetic and environmental syndromes. Fifth, re-
searchers have grouped ASD genetic risk genes theorized to
produce a narrowed set of disrupted brain circuits.
Brain Validity Research Approach 1: Is There a Specific
ASD Brain Impairment?
Findings for ASD global and regional brain sizes have been
varied. Riddle et al. (2016) found that 443 individuals with
ASD had a 2.17 % increase in gray matter compared to 390
typically developing (TD) individuals, but found no group dif-
ference in white matter. However, when Riddle et al. (2016)
compared matched subsamples of 300 ASD and TD children,
no differences between TD and ASD white matter or gray
matter were found. Vasa et al. (2012) reported that only 8 of
73 individuals diagnosed with ASD had any atypical brain
features. Lenroot and Yeung (2013) reported that the majority
of individuals diagnosed with ASD had typical brain and head
size. However, in other studies, approximately 10 to 24 % of
individuals diagnosed with ASD had persisting macrocephaly
(Gillberg and de Souza 2002; Lainhart 2015; Nebel et al. 2015;
Sacco et al. 2015; Tammimies et al. 2015). In addition, a num-
ber of studies have reported that 3 to 15 % of individuals with
ASD had persistingmicrocephaly (Gillberg and de Souza 2002;
Nebel et al. 2015; Roullet et al. 2013; Stevens et al. 2013).
Although Riddle et al. (2016) found no regional brain dif-
ferences in 443 individuals with ASD compared to 390 TD
individuals, Lefebvre et al. (2015) noted that many studies had
found significantly smaller corpus callosum in ASD than TD
controls. By contrast, Lefebvre et al. (2015) found no differ-
ence in corpus callosum size in their sample of 694 individuals
with ASD compared to TD controls. Studies of the amygdala
in ASD have reported significantly Bincreased, decreased and
preserved volumes^ of the amygdala (Bellani et al. 2013,
p. 3). Similarly, Stigler et al. (2011) noted that studies have
reported increased, decreased, and typical (preserved) vol-
umes for the fusiform gyrus in ASD.
D’Mello et al. (2015) reported that ASD was characterized
by reduced gray matter in the cerebellum in lobule VII.
However, a consensus paper on the cerebellum in ASD
(Fatemi et al. 2012) concluded that only a subgroup of ASD
had atypical cerebellar anatomy, and this was a smaller cere-
bellar vermis volume and fewer Purkinje cells. Studies of the
brainstem in ASD have reported both typical and atypically
smaller volumes of brainstem gray matter (Jou et al. 2013).
Despite evidence for abnormal auditory brainstem response
(ABR) in ASD (Rosenhall et al. 2003; Lukose et al. 2015),
Jou et al. (2013) concluded that ASD brainstem studies were
conflicting and inconclusive.
SummaryASD global and regional brain structures are varied
and do not provide brain structure biological validity for ASD.
To date, no unitary atypical brain size or volume has been
found for ASD, and no unitary atypical ASD regional brain
structure has been found. Equally important, varied ASD elec-
trophysiology findings (Billeci et al. 2013) and varied ASD
molecular neurochemistry findings (Zürcher et al. 2015) stand
against the idea that there is any shared single ASD brain
impairment in electrophysiology or molecular neurochemistry.
Of course, research has not uncovered the full complexity
of human brain development, functions, and networks (Sporns
and Betzel 2016). When much more is known about the
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emergence of regional functions and connectivity of the brain,
it may be possible in the future to establish a unitary model of
ASD brain impairment.
Brain Validity Research Approach 2: Is There
a Replicated ASD Brain Impairment Model?
Hundreds of unitary models of ASD brain impairment have
been theorized and studied. For example, Baron-Cohen et al.
(2015) proposed that ASD stemmed from fetal steroidogenic
abnormalities. Fishman et al. (2014) proposed that ASD re-
sulted from atypical overconnectivity of the brain’s mirror
neuron regions and theory of mind regions. By contrast,
Khan et al. (2015) proposed that ASD resulted from
underconnectivity in local brain regions when activated by a
Bfunctionally relevant task^ (p. 1407). Mullins et al. (2016)
posited that mutations in the FMR1 gene and TSC genes dis-
rupt long-term depression (LTD) and long-term potentiation
(LTP), and therefore, these mutations in ASD cause atypical
LTP and LTD processes that impair the excitation-inhibition
balance in brain development and function which determines
ASD (Mullins et al. 2016).
Robertson et al. (2015) claimed that the Bprime suspect^
single cause for ASDwas disrupted GABAergic signaling that
impaired neurodevelopment and cortical computations.
However, Estes and McAllister (2015) theorized that ASD
was caused by atypical immune system factors that converged
on the MEF2 and mTOR signaling hubs and thus disrupted
the brain’s developmental synaptic function and plasticity.
Irimia et al. (2014) theorized a basis for ASD brain impair-
ment in atypically greater misregulation of nSR100-
dependent microexons. Focusing on early visual attention in
ASD, Klin et al. (2015) posited that the developmental failure
of the reward-based interactional eye fixation to co-opt the
brain’s innate reflexive eye fixation caused ASD.
Because these eight theories explain different aspects of ASD
brain function, they are not necessarily mutually exclusive.
However, there has been no attempt to synthesize any subset
of these eight theories, or synthesize any subset of prior unitary
ASD brain theories (Waterhouse 2008). Most importantly, no
unitary brain impairment theory to date has been replicated to
become a standard explanation of ASD brain disruption.
The theory with the most active support argues that ASD
results from impaired brain connectivity that is likely to have
been preceded by early brain overgrowth (Solso et al. 2015;
Stoner et al. 2014; Venkataraman et al. 2015). Although the
underconnectivity theory has been studied formore than 15 years
(Just et al. 2004) and has many supporters (Anderson 2013;
Dawson 2016; Ecker et al. 2015; Green et al. 2015; Shen et al.
2013), nonetheless, this theory has not become standard because
there is as much evidence against the theory as there is for it.
Supporting the existence of early ASD brain overgrowth,
Ecker et al. (2015) asserted that, on average, toddlers with
ASD have Ba larger brain volume than typically developing
children^ (p. 1), and Shen et al. (2013) and Anderson (2013)
reported that ASD was characterized by atypical early brain
overgrowth. Sussman et al. (2015) reported that early brain
overgrowth was limited to males with ASD, and Chaste et al.
(2013) found that the subgroup of ASD with an atypically
larger head circumference expressed greater symptom severity
and lower IQ.
Counter to the early brain overgrowth model, though,
Chaste et al. (2013), Raznahan et al. (2013), and Cederlund
et al. (2014) all concluded that very few children with ASD
had early brain overgrowth, and Raznahan et al. (2013) report-
ed that larger ASD head circumference was not found when
local TD controls were used. Lainhart (2015) reviewed re-
search and noted that only Ba very small subgroup of ASD
children^ (p. 79) had larger brain volumes. In a meta-analysis,
Sacco et al. (2015) found only 5.7 % of individuals with ASD
had macrocephaly and just 9.1 % had brain overgrowth.
Tammimies et al. (2015) also found that only 63 of 258 chil-
dren with ASD had macrocephaly. Also countering the ASD
early brain overgrowth model, 3 to 15 % of individuals diag-
nosed with ASD have been born with microcephalic brains
(Nebel et al. 2015; Roullet et al. 2013; Stevens et al. 2013).
Most importantly, the generalizability of the ASD early brain
overgrowth model is limited by the evidence that the majority
of individuals diagnosed with ASD have typically developing
head and brain growth (Lenroot and Yeung 2013; Nebel et al.
2015; Riddle et al. 2016; Vasa et al. 2012).
Supporting the malconnectivity component of the currently
dominant model, Dawson (2016) asserted that Blong-range
connections between different brain regions are weaker in
people with ASD^ (para. 4). Venkataraman et al. (2015) de-
termined that ASD brain malconnectivity occurred in two net-
works: a language network including temporal lobe areas and
a Bsocial-person^ network including temporal and parietal
areas. Venkataraman et al. (2015), however, found no impair-
ment in ASD frontal lobe connectivity. Conversely,
Kitzbichler et al. (2015) reported that ASD malconnectivity
was centered in frontal lobe-linked connections.
Counter to both Kitzbichler et al. (2015) and Venkataraman
et al. (2015), though, Redcay et al. (2013) reported finding no
evidence for atypical connectivity in ASD. Tyszka et al.
(2014) also stated that their ASD sample showed, Bno evi-
dence at all for altered connectivity at the whole-brain level^
(pp. 7–8). Kirkovski et al. (2015) found no differences be-
tween high functioning individuals with ASD and typical con-
trols in white matter in major tract bundles determined by any
method: fractional anisotropy (FA), mean diffusivity (MD),
radial diffusivity (RD), or axial diffusivity (AD). Koldewyn
et al. (2014) reported finding no general impaired white matter
in ASD. Lefebvre et al. (2015) found no differences between
694 individuals diagnosed with ASD and typical controls in
the largest white matter tract in the brain—the corpus
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callosum. The researchers questioned whether any regional
ASD malconnectivity model could be meaningful because
most of the brain is involved in connectivity (Lefebvre et al.
2015).
Another problem for standardizing the overgrowth-
malconnectivity model is that there are so many different ver-
sions of this model (Fishman et al. 2014; Kennedy et al. 2015;
Khan et al. 2015; Kitzbichler et al. 2015; Venkataraman et al.
2015). As noted by Kennedy et al. (2015), Bthe connectivity
hypothesis has been vague ever since its inception… slowly
morphing from a theory about underconnectivity in ASD, to
one about distal underconnectivity paired with local
overconnectivity, to one about atypical connectivity in either
direction (or both)^ (p. 81).
Summary No ASD brain impairment model has been
adequately replicated to become standard, and thus, no
existing model provides neurobiological validity for
ASD.
Despite intense research efforts, the malconnectivity model
has not been successfully replicated (Ecker et al. 2015;
Kennedy et al. 2015; Khan et al. 2015; Lefebvre et al.
2015), and neither has any of the myriad other unitary ASD
brain impairment models. Moreover, none of these models has
accounted for the variation in ASD global and regional brain
structures, or the variation in ASD electrophysiology findings
(Billeci et al. 2013), or the variation in neurochemistry find-
ings (Zürcher et al. 2015).
Brain Validity Research Approach 3: Is Each ASD
Diagnostic Symptom Caused by a Distinct Brain
Impairment?
Many studies have looked for the biological validity of indi-
vidual ASD diagnostic and associated nondiagnostic symp-
toms (Anderson et al. 2014; Boucher 2011; Brunsdon and
Happé 2014; Chen et al. 2015; Harrop et al. 2013;
Hormozdiari et al. 2015; Jason et al. 2015; Pina-Camacho et al.
2012; Shuster et al. 2014).
Is ASD Social Impairment Linked to a Unique Brain
Impairment?
DSM-5 defines ASD diagnostic social impairment as persis-
tent impaired social reciprocity, with impaired social nonver-
bal communication behaviors, along with an inability to de-
velop and maintain relationships. Pina-Camacho et al. (2012)
analyzed multiple studies of the association between ASD
symptoms and brain impairments and reported that ASD di-
agnostic social impairment was linked to four distinct regional
brain dysfunctions. The face-fusiform area (FFA) was found
as the basis for ASD social impairment, and the
frontotemporal cortical networks including mirror neuron
system circuits were found as the basis for ASD social impair-
ment (Pina-Camacho et al. 2012). Still other findings impli-
cated dysfunction of the anterior cingulate cortex (ACC) in
ASD social impairment, and finally, some research suggested
that ASD social behaviors were impaired by disruptions in the
subcortical amygdala-hippocampal network (Pina-Camacho
et al. 2012).
In addition to the brain regions reported by Pina-Camacho
et al. (2012), Ecker et al. (2012) claimed that ASD diagnostic
social impairment was specifically linked to Ba significant
decrease in gray matter volume in a large cluster located in
the occipital and medial parietal regions^ (p. 202). However,
Ecker et al. (2015) later asserted that impaired ASD social
communication resulted from dysfunctions in Broca’s and
Wernicke’s areas, while impaired ASD social/emotional com-
prehension resulted from dysfunctions in frontotemporal re-
gions and the amygdala.
Zilbovicius et al. (2013) reported that ASD diagnostic so-
cial impairment was linked to abnormalities in the superior
temporal sulcus (STS), including decreased gray matter and
hypoperfusion at rest. Maillard et al. (2015) found that diag-
nostic ASD social impairment and chromosomal number var-
iant (CNV) 16p11.2 carrier social impairment were both
linked to brain dysfunctions in left and right putamen,
insula, posterior cingulate, thalamus, and superior temporal
gyrus. By contrast, Byrge et al. (2015) reported that five (of
17) individuals diagnosed with ASD all had profound diag-
nostic social impairment but none of the five shared any spe-
cific atypical brain dysfunction. Instead, these five individuals
expressed five different idiosyncratic brain responses to ob-
served social interaction (Byrge et al. 2015).
Ameis and Catani (2015) reported that three different
methods yielded different brain bases for ASD social impair-
ment. Ameis and Catani (2015) noted that while neuropathol-
ogy studies found frontolimbic pathways linked to ASD diag-
nostic social impairment, MRI imaging studies did not.
Instead, Ameis and Catani (2015) reported that MRI imaging
studies found early atypical brain growth and atypical volume
of frontal white matter linked to ASD social impairment.
Finally, fMRI findings differed from both neuropathology
and MRI findings, linking ASD diagnostic social impairment
to decreased temporal lobe activity and decreased frontal lobe
activity. Ameis and Catani (2015), in turn, theorized that the
brain basis for ASD diagnostic social impairment was
disrupted uncinate fasciculus and thalamic projections to pre-
frontal and temporal lobes.
Are ASD Diagnostic Repetitive Behaviors, Restricted
Interests, and Resistance to Change, Together Identified
as the RRBs, Linked to a Unitary Brain Impairment?
The DSM-5 ASD diagnosis now requires the presence of two
of four behaviors of any of the RRBs, and/or atypical sensory
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responsiveness. Pina-Camacho et al. (2012) reviewed multi-
ple studies of the brain basis of the RRBs and reported that six
distinct brain regions had been linked to ASD RRBs. One
brain region was the frontocerebellar network, and another
region was the frontostriatal system (Pina-Camacho et al.
2012). Fourmore regions linked to the RRBswere the anterior
and posterior cingulate, some posterior parietal regions, the
posterior regions of corpus callosum, and the cerebellar ver-
mis and peduncles (Pina-Camacho et al. 2012).
The RRBs have also been linked to specific frontal lobe
structural abnormalities (Ecker et al. 2012), and the RRBs
have been linked to atypical caudate overgrowth (Langen
et al. 2014). By contrast, Doyle-Thomas et al. (2014) reported
that RRBs in general were associated with atypically low
choline/creatine in the thalamus, whereas ASD social impair-
ment was not. In addition, Gabriels et al. (2013) reported that
the general severity of RRBs was inversely correlated with
daytime cortisol levels.
Are ASD Nondiagnostic Symptoms Linked to Specific Brain
Impairments?
Although ASD diagnostic criteria specifically exclude many
neurodevelopmental symptoms such as intellectual disability
(ID), language delay, language impairment, attention deficits,
and seizures, more than 96 % of those diagnosed with ASD
actually express one or more of these symptoms and/or other
non-ASD symptoms (Lundström et al. 2015b). The preva-
lence of non-ASD neurodevelopmental symptoms varies.
ADHD symptoms were found in 17 to 83 % of individuals
with ASD (Matson et al. 2013; Nebel-Schwalm and Worley
2014). ID has been reported in 50–70 % of individuals with
ASD (Matson and Williams 2014). Nearly 100 % of individ-
uals diagnosed with ASD have been found to exhibit mutism,
or language delay, or language impairment (Boucher 2012).
Finally, 40 % with ASD have experienced seizures (Amiet
et al. 2013), and 60 % with ASD have exhibited epileptiform
brain activity (Mulligan and Trauner 2014).
Variation in the pathophysiology of non-ASD epilepsy is
very similar to the variation in the pathophysiology of epilep-
sy in ASD (Amiet et al. 2013; Blackmon 2015; Stafstrom and
Carmant 2015). Some epilepsy is the result of malformations
of cortical development (MCDs), including focal cortical dys-
plasia and heterotopias, and these malformations have been
found in ASD (Blackmon 2015).
Attention problems are inherent in some ASD criteria, such
as the preoccupation with unusual objects, and up to 83 % of
those with ASD have expressed ADHD symptoms (Nebel-
Schwalm and Worley 2014). However, before DSM-5, ASD
and ADHD could not be diagnosed together in one individual.
Johnson et al. (2015) reported that frontal lobe impairments
and hypo- and hyperconnectivity have been reported for both
ASD and ADHD. Johnson et al. (2015) also noted that some
studies found slower early brain size increase in both ADHD
and ASD.
Up to 70 % of individuals with ASD express ID, and some
of the comorbidity of ASD and ID is known to stem from
shared gene risk factors. For example, 17 % of all ID risk
genes with de novo loss of function (LoF) mutations are also
reported for ASD (Vissers et al. 2016). Both ASD and ID have
been found with gene variants that cause impairment in many
aspects of brain development and function, including
neurogenesis, neuronal migration, synaptic function, and reg-
ulation of transcription and translation (Vissers et al. 2016).
Mayes et al. (2015) found that language impairment in
children without ASD was associated with atypical structure
and function in traditional language regions including the
inferior frontal gyrus, posterior superior temporal gyrus, and
caudate nucleus. As noted earlier, Venkataraman et al. (2015)
reported that ASD included impaired brain connectivity in
language regions including right temporal pole, left posterior
cingulate cortex, left supramarginal gyrus, and left middle
temporal gyrus. ASD has also been found with both decreased
and increased rightward functional activation of language cor-
tex (Joseph et al. 2014).
Summary Each of the two ASD core diagnostic symptoms
has been found with multiple varied brain impairments; thus,
each core ASD diagnostic symptom lacks neurobiological
validity.
Neither core ASD diagnostic symptom has been linked to a
single consistent brain impairment. Moreover, nondiagnostic
symptoms commonly found with ASD, such as ID, ADHD,
language impairments, and seizures, each occur with varied
brain impairments.
That ASD social impairment is found with so many varied
brain impairments may reflect the many different and
interconnecting brain systems that shape typical human social
behaviors (Barrett and Satpute 2013; Doré et al. 2014). The
varied brain impairments, in turn, may, in part, reflect the
myriad genes that regulate the structure and function of social
brain systems (Weitekamp and Hofmann 2014; Westberg and
Hasse Walum 2015).
The many varied brain impairments found with the RRBs
may be consonant with the variation in the types of RRBs. The
RRBs include stereotyped movements, repetitive manipula-
tion of objects, repetitive self-injurious behavior, specific ob-
ject attachments, compulsions, rituals and routines, an insis-
tence on sameness in the environment, repetitive use of lan-
guage, as well as narrow and circumscribed interests (Bishop
et al. 2013; Leekam et al. 2011). Given this wide range of
RRB behaviors, it is possible that, in part, different forms of
RRBs may be caused by different brain dysfunctions.
Finally, nondiagnostic symptoms found with ASD such
as ID and language dysfunction have many different brain
bases reflecting the wide variation in ASD etiology.
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Brain Validity Research Approach 4: Are Syndromic ASD
Diagnostic Symptoms Caused by an Independent Unique
ASD Brain Impairment?
Syndromic ASD is found with a known genetic or environ-
mental syndrome, such as fragile X syndrome (FXS) or
valproate syndrome. Syndromic ASD occurs with
Mendelian single gene syndromes, CNV syndromes, and en-
vironmental syndromes. Although syndromic ASD has been
estimated to account for only 5 to 25 % of all cases of ASD
(Adviento et al. 2014; de la Torre-Ubieta et al. 2016; Jeste and
Geschwind 2014), more forms of syndromic ASD continue to
be identified (Adviento et al. 2014; Richards et al. 2015;
Roullet et al. 2013; Smile et al. 2013; Yu and Berry-Kravis
2014; Yuen et al. 2015). In addition, syndromic and idiopathic
ASD brain impairments have been reported that are
similar (Adviento et al. 2014; Blackmon 2015; D’Angelo et al.
2015; Guilmatre et al. 2014; Klusek et al. 2015; Sala et al.
2015).
The key question is whether syndromic ASD diagnostic
symptoms are caused by an independent brain impairment
unique to ASD. For example, when ASD occurs with cerebral
palsy (Smile et al. 2013), are ASD diagnostic symptoms
caused by an ASD-specific brain connectivity problem? Or
are ASD diagnostic symptoms caused by characteristic cere-
bral palsy gray matter injuries, brain malformations, and focal
vascular insults? If syndromic ASD symptoms do not result
from an independent ASD-specific brain impairment, then
ASD diagnostic symptoms in syndromic ASD must result
from widely varied brain impairments.
Peters et al. (2013) and Tye and Bolton (2013) argued for an
independent unique ASD brain impairment in syndromic ASD.
Peters et al. (2013) asserted that in syndromic ASD with tube-
rous sclerosis complex (TSC), the TSC brain tubers and TSC
malorganization of the brain caused TSC symptoms, but that
brain underconnectivity was independently and uniquely causal
for ASD alone. The researchers found that underconnectivity
occurred in syndromic ASD with TSC, and in idiopathic ASD,
but not in TSC alone. Similarly, Lainhart (2015) claimed that
syndromic ASD with TSC and idiopathic ASD both expressed
the ASD-specific reduced long-range connectivity with in-
creased short-range connectivity.
However, Jeste and Geschwind (2014), Hall et al. (2010),
and Adviento et al. (2014) proposed that syndromic ASD
arose from the syndrome’s brain impairments. Specifically,
for the case of syndromic ASD with TSC, Jeste and
Geschwind (2014) argued that the TSC brain tubers and
TSC malorganization of the brain that caused TSC
symptoms also simultaneously caused ASD symptoms. Jeste
and Geschwind (2014) argued that both ASD and TSC
symptoms resulted from TSC tubers that occurred in the
temporal, frontal, and occipital cortex and in the cerebellum,
because these tubers cause many brain impairments, including
disorganized axonal tracts, increased axonal growth, abnormal
myelination, aberrant synapse formation, and aberrant white
matter organization. Similarly, for syndromic ASD with FXS,
Hall et al. (2010) argued that an individual with FXS who
expressed ASD symptoms did not have two disorders, but
had one genetic disorder, FXS, that caused one brain impair-
ment, the lack of fragile X mental retardation protein (FMRP)
that, in turn, caused both FXS symptoms and ASD symptoms.
Gabis and Pomeroy (2014) also supported the single brain im-
pairment model of syndromic ASD with evidence suggesting
that ASD symptoms expressed in syndromic ASD likely result-
ed from a unitary Bbiological or neural pathway^ (p. 297).
Genetic Syndromic ASD Has Been Found with Varied Brain
Impairments
There are many forms of genetic syndromic ASD (Cederlöf
et al. 2014; Kern et al. 2015; Plasschaert et al. 2015; Poot
2015; Richards et al. 2015). The fact that many different ge-
netic syndromes do yield ASD diagnostic symptoms is the
result of locus heterogeneity, wherein different gene variants
produce the same phenotype, or the same phenotypic trait or
symptom. Syndromic ASD has been found with genetic syn-
dromes called RASopathies that are caused by mutations in
Ras/mitogen-activated protein kinase (Ras/MAPK) expres-
sion genes. Adviento et al. (2014) reported that ASD occurred
in four RASopathies: neurofibromatosis type 1 (NF1),
Noonan syndrome (NS), Costello syndrome (CS), and
cardio-facio-cutaneous syndrome (CFC). Syndromic ASD
has also been found with the Shankopathies, which are genetic
syndromes caused largely by mutations in SHANK2, and
SHANK3 genes (Guilmatre et al. 2014; Leblond et al. 2014;
Sala et al. 2015). Many genetic variants, like the mutations in
SHANK2 and SHANK3, have pleiotropic effects, that is, a
single mutation results in a variety of phenotypes. A mutation
in SHANK3 has the pleiotropic effect of generating four sep-
arate diagnostic phenotypes: ASD, schizophrenia (SCZ), se-
vere ID, and epilepsy (Guilmatre et al. 2014; Leblond et al.
2014; Sala et al. 2015). Hommer and Swedo (2015) noted that
SHANK3 mutations, and the 22q11.2 deletion syndrome, and
duplications at the Williams syndrome locus (7q11.23) all
pleiotropically generated both the ASD and SCZ phenotypes.
However, the ACD and SCZ phenotypes had disrupted deep
layer cortical projection neurons in different brain locations; in
ASD, the disruption occurred in the prefrontal and primary
motor-somatosensory regions, but in SCZ, the disruption oc-
curred in the dorsolateral and ventrolateral prefrontal cortical
regions (Hommer and Swedo 2015).
ASD has frequently been reported with the Phelan-
McDermid syndrome caused by the CNV chromosome
22q13 deletion that disrupts the gene SHANK3. The
SHANK protein regulates synaptic cell adhesion molecules
and cell scaffolding in brain development via dendrites and
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glutamatergic synapses. SHANK2 and SHANK3 gene muta-
tions reduce the total number of dendritic spines and synapses
on neurons, and the lack of mature glutamatergic synapses
appears to cause the impaired brain function that results in
ID and ASD symptoms.
In a meta-analysis of 168 papers, Richards et al. (2015)
reported varied rates of syndromic ASD across 11 genetic
syndromes. Richards et al. (2015) reported that of those diag-
nosed with Rett’s syndrome (RTT), 61 % were found to have
ASD diagnoses, and of those with Cohen’s syndrome, 54 %
had ASD, while for Cornelia de Lange syndrome, 43 % had
ASD. Richards et al. (2015) also noted that of those with TSC,
36 % were diagnosed with ASD; for those with Angelman’s
syndrome, 34% had ASD; for CHARGE syndrome, 30% had
ASD; and also 30 % of males with FXS were found to be
diagnosed with ASD. Richards et al. (2015) further reported
that 18 % of those diagnosed with NF1 had ASD diagnoses,
and the rate of ASD for Down’s syndrome was 16 %, for NS
was 15 %, and for Williams’ syndrome was 12 %. Finally, the
researchers reported that 11% of those found with the 22q11.2
deletion syndrome met the criteria for an ASD diagnosis.
Genetic syndromes found with ASD diagnostic symptoms
also occur without ASD diagnostic symptoms. For example,
the Cornelia de Lange syndrome, which is caused by muta-
tions in NIP-BL, SMC3, and X-linked SMC1A and HDAC8
genes, occurs with and without ASD diagnostic symptoms
(Moss et al. 2012). However, with or without ASD diagnostic
symptoms, Cornelia de Lange syndrome involves ID, social
anxiety, and mutism. Similarly, the RASopathy syndromes
NS, CS, and CFC have all been reported with and without
ASD diagnostic symptoms. With or without ASD diagnostic
symptoms, NS, CS, and CFC are consistently characterized by
atypical head and face development, brain lesions, and im-
paired cognition.
Research has demonstrated that syndromic ASD and idio-
pathic ASD may cause similar brain impairments. As noted
above, ASD occurs with four Ras/MAPK syndromes: NF1,
NS, CS, and CFC. However, ASD has also occurred with
CNVs and single nucleotide polymorphisms (SNPs) that dis-
rupt the Ras/MAPK pathway (Adviento et al. 2014). These
CNVs and SNPs do not technically cause a RASopathy syn-
drome such as Noonan syndrome; nonetheless, these CNVs
and SNPs result in the same brain impairments as those found
with the RASopathy syndromes. Similarly, while syndromic
ASD occurs with SHANK genemutations, idiopathic ASD has
been found with mutations in neuroligin genes, including
NLGN2 and NLGN3, and mutations in neurexin (NRXN)
genes, whose deleterious effects on synaptic cell adhesion
molecules and cell scaffolding are very much like the delete-
rious effects of SHANK gene mutations and the Phelan-
McDermid 22q13 deletion.
Another example linking syndromic and idiopathic ASD is
that some individuals with idiopathic ASD have expressed
hyperarousal, dampened parasympathetic tone, and atypical
reactivity, and these same symptoms have been found for
syndromic ASD with FXS (Klusek et al. 2015). In syndromic
ASD with FXS, these arousal and reactivity deficits result
from brain dysfunction caused by the genetic mutation of
the FMR1 gene, and therefore, Klusek et al. (2015) argued
that these symptoms in idiopathic ASD must result from brain
impairments that are similar to those caused by FMR1 gene
mutations.
Genetic syndrome risk factors and individual nonsyndromic
genetic mutations may also together contribute to an individual
case of autism, and multiple nonsyndromic genetic mutations
may also operate together (De Rubeis and Buxbaum
2015; Jiang et al. 2013; Lim et al. 2013; Murdoch and State
2013; Sanders et al. 2015), such that Beach individual gene
accounts for a small fraction of ASD^ (Lim et al. 2013,
p. 240). Combinations of CNVs also work together to cause
ASD. For example, D’Angelo et al. (2015) reported that ASD
was linked to both the CNV 16p11.2 BP4-BP5 duplication and
the CNV 16p11.2 BP4-BP5 deletion. However, D’Angelo et al.
(2015) found that those individuals who had the duplication of
16p11.2 BP4-BP5 also had many additional deleterious CNVs,
but those with the 16p11.2 BP4-BP5 deletion did not have
additional deleterious CNVs. This indicated that the duplication
form had less damaging brain effects, because it required the
presence of additional deleterious CNVs to produce a brain
impairment that could yield ASD diagnostic symptoms.
Similarly, syndromic ASD brain impairment may be bur-
dened by the additional deleterious effects of other gene var-
iants. Wassink et al. (2014) studied syndromic ASD with FXS
in relation to a low activity allele of the MAOA gene that is
linked to impaired arousal regulation, aggression, impaired
social communication skills, and cortical enlargement.
Wassink et al. (2014) found that when individuals with
syndromic ASD with FXS, idiopathic ASD, and FXS without
ASD carried the low activity MAOA allele, all three groups
had identical atypical increases in gray matter and white mat-
ter. Thus, theMAOA allele functioned identically in three dif-
ferent diagnoses—idiopathic ASD, ASD with FXS, and FXS
alone.
Environmental Syndromic ASD Has Been Found with Varied
Brain Impairments
There are fewer defined environmental ASD syndromes than
genetic ASD syndromes, but there are numerous ASD envi-
ronmental risk factors (Boukhris et al. 2015; Croen et al. 2011;
Grabrucker 2013; Hviid et al. 2013; Lyall et al. 2014;
Maramara et al. 2014; Ornoy et al. 2015; Rossignol et al.
2014; Schieve et al. 2014). Ornoy et al. (2015) reviewed
ASD environmental risk factors and reported 17 significant
prenatal, perinatal, and postnatal risk factors: maternal inflam-
mation and immune activation, rubella, cytomegalovirus
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(CMV), influenza, fever, diabetes, folic acid deficiency, toxo-
plasmosis; exposure to ethanol, cocaine, valproic acid, miso-
prostol, thalidomide, antidepressant serotonin reuptake inhib-
itors (SSRIs); and exposure to pesticides, insecticides, and air
pollution. Also, Maramara et al. (2014) found 15 significant
ASD prenatal, perinatal, and postnatal risk factors in a single
study sample: father’s age, mother’s age, maternal drug and
alcohol use, maternal hypertension during pregnancy, gesta-
tional diabetes, vaginal bleeding, cesarean section, prematuri-
ty, induced labor, prolonged labor, lack of infant oxygen dur-
ing delivery, low birth weight, newborn jaundice, and new-
born infection.
Though not every ASD environmental risk factor is iden-
tified as a syndrome, many environmental syndromes have
been identified. For example, Roullet et al. (2013) reported
that ASD was seven times more frequent in infants born to
mothers who took valproic acid during their first trimester to
control epilepsy, or as a mood stabilizer for bipolar disorder.
Children with fetal valproate syndrome (FVS) who express
ASD symptoms are likely to have ID, microcephaly, and var-
ied other physical disabilities. In addition, children with fetal
alcohol syndrome (FAS) have also expressed ASD symptoms
(Stevens et al. 2013). FAS is found with an atypically smaller
brain, and an impaired, or atypically small, or missing corpus
callosum.
Kuzniewicz et al. (2014) reported that ASD is associated
with prematurity, and the risk of ASD increases with decreas-
ing gestational age at birth: the rate of ASD was three times
higher in infants born at less than 27 weeks gestational age.
Kuzniewicz et al. (2014) also reported that intracranial hem-
orrhage (ICH) in premature infants was also associated with a
higher rate of ASD.
Even pollution has been linked to ASD. Kalkbrenner
et al. (2014) theorized that five chemicals contributed to
ASD by disrupting endocrine system development:
polychlorinated biphenyls (PCBs), flame retardants, non-
stick chemicals, bisphenol A (BPA), and phthalates.
However, pollution risk findings have been variable.
Boggess et al. (2016) pooled heavy metals and organic
pollutants into a single variable of xenobiotic exposure
and reported that xenobiotic exposure level correlated
with severity of ASD communication impairment
(p = .02) and ASD social impairment severity (p = .05).
Conversely, Guxens et al. (2015) found no link between
prenatal air pollution and ASD in a study of 8000
children.
Volk et al. (2014), however, demonstrated that if individ-
uals homozygous for the C allele of the MET gene were ex-
posed to air pollution, they had an increased ASD risk rate of
2.9 (1.0–10.6). The C allele of the MET gene reduces gene
transcription by 50 %, disrupting the brain’s structural net-
works, resting state connectivity, and social-emotional infor-
mation processing. The process by which the C allele of the
MET gene reduces gene transcription is likely to be further
disrupted by the xenobiotics in air pollution. This and other
gene variant-environment interaction findings suggest that xe-
nobiotics may add to existing genetic vulnerability.
Summary Evidence indicates that many varied brain impair-
ments cause syndromic ASD diagnostic symptoms, thus pro-
viding no neurobiological validity for ASD.
The ASD diagnosis has been found with more than 100
genetic and environmental syndromes, and these syndromes
are found with varied brain impairments. Although similar
brain impairments have been reported for some types of
syndromic and idiopathic ASD, the wide variation in
syndromic ASD brain impairments argues that there is no
unitary brain basis for ASD diagnostic symptoms.
Moreover, the etiology of brain impairments in both
syndromic and idiopathic ASD is complex. Syndromic ASD
may occur with additional deleterious syndromic or nonsyn-
dromic genetic mutations, and syndromic and idiopathic ASD
brain impairments may stem from the interaction of multiple
genetic risk factors, or from the additive effect or interaction of
multiple genetic and environmental risk factors.
Brain Validity Research Approach 5: Do Multiple ASD
Genes Disrupt Few Brain Circuits?
Some researchers have theorized that a network or networks
of multiple ASD risk genes disrupt just a few impaired brain
circuits or pathways in ASD (Chen et al. 2015; de la Torre-
Ubieta et al. 2016; Ecker et al. 2015; Geschwind and State
2015; Parikshak et al. 2013; Ruggeri et al. 2014; Willsey et al.
2013). For example, de la Torre-Ubieta et al. (2016) stated
Bevidence from known mutations does suggest significant
convergence in the pathways in which the mutations are
found^ (p. 349). Willsey et al. (2013) predicted that ASD risk
genes together would yield, Ba much smaller set of underlying
pathophysiological mechanisms^ (p. 1004), and Geschwind
and State (2015) also proposed that ASD genetic risk factors
would converge on only a few Bspecific molecular pathways
or brain circuits^ (p. 9).
There is evidence that ASD risk gene variants do converge
on specific brain tissue in development (Parikshak et al. 2013;
Willsey et al. 2013). Willsey et al. (2013) reported that nine
ASD risk genes were expressed in one brain development
layer at a shared time of mouse fetal brain growth. Parikshak
et al. (2013) reported that ASD risk genes were linked to
Blaminae containing postmitotic neurons during early fetal
development…(and) upper-layer glutamatergic neurons in
adult cortex^ (p. 1118). Ziats and Rennert (2016) lauded the
findings ofWillsey et al. (2013) and Parikshak et al. (2013) for
providing evidence Bthat a few common mechanisms may
ultimately relate the heterogeneous set of ASD candidate
genes to one another^ (p. 4).
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However, there are limits to the explanatory power of the
Bmultiple genes-few brain circuits^ model because Bthe func-
tion of most known genes is not fully understood; the group-
ing of affected genes is often arbitrary; and the concepts of
pathways and networks are based on biochemistry, whichmay
not be appropriately capturing the complex scenarios of the
true biological system^ (Vissers et al. 2016, p. 5). Most of the
nearly 800 identified ASD risk genes (Butler et al. 2015) are
not yet well understood, and the full extent of polygenicity for
ASD is not yet known. It could be that ASD polygenicity is as
great as that found for schizophrenia (SCZ). Loh et al. (2015)
reported SCZ was so polygenic that most of the human ge-
nome contained SCZ-linked loci, raising the concern that a
future more powerful analysis could link SCZ to the entire
human genome, making genetic analysis effectively
uninformative.
Yet another difficulty for the ASDmultiple genes-few brain
circuits model is that there are many known functional gene
pathway groups. For example, Wen et al. (2016) found ASD
risk genes in pathways for cell signaling, metabolism, neuro-
active ligand-receptor interaction, and nervous system
development. Wen et al. (2016) noted yet another ASD genet-
ics inference problem. The researchers reported that the
MAPK signaling pathway and the calcium signaling pathway
that were central to the ASD pathway network were integrated
by BASD genes that encode proteins functioning in multiple
steps^ (Wen et al. 2016, p. 16). Because these proteins affect
multiple body systems and thus can cause problems
throughout the body, Wen et al. (2016) concluded that ASD
symptoms were likely to be caused Bby underlying more per-
vasive processes that are not specific toASD brain or behavior
features^ (p. 13).
Another concern is that some Bmultiple genes yielding few
disrupted brain circuits^ models have not addressed known
variation in ASD brain impairments. For example, Parikshak
et al. (2013) stated that gene variants disrupted laminae in fetal
development that resulted in upper-layer glutamatergic neuron
malconnectivity that was the malconnectivity that defined
ASD. However, Parikshak et al. (2013) did not discuss the
evidence that many with ASD have no brain malconnectivity
(Redcay et al. 2013; Tyszka et al. 2014). Thus, the Parikshak
et al. (2013) model cannot apply to ASD in general. Parikshak
et al. (2013) also proposed that the chromatin remodeling
ASD risk gene ARID1B caused the corpus callosum abnor-
malities that characterized ASD. Here again, Parikshak et al.
(2013) did not discuss evidence that many with ASD have no
corpus callosum abnormalities (Lefebvre et al. 2015).
Consequently, the role of the ARID1B risk gene in ASD can-
not be generalized.
Finally, models of multiple genes disrupting a few brain
circuits have ignored ASD environmental risk factors. For
example, de la Torre-Ubieta et al. (2016) stated that ASD
genetic risk factors caused Bdeficits in neurogenesis, cell fate,
neuronal migration and morphogenesis during fetal develop-
ment and dysregulated synaptic function^ (p. 349). This in-
ventory does not include intracranial hemorrhage effects
found in ASD diagnosed with extreme prematurity
(Kuzniewicz et al. 2014), or the brain cysts and apoptosis
of neurons infected with cytomegalovirus (CMV) found for
ASD occurring with congenital CMV infection (Engman et al.
2015).
While evidence suggests that gene variants are the domi-
nant cause of the pathophysiology of ASD symptoms, just as
gene variants have been found to be the dominant cause for
most human traits and disorders (Polderman et al. 2015), there
are significant findings for many ASD environmental risk
factors (Boukhris et al. 2015; Grabrucker 2013; Lyall et al.
2014; Maramara et al. 2014; Ornoy et al. 2015; Rossignol
et al. 2014; Schieve et al. 2014). Moreover, heritability studies
have variably calculated ASD environmental risk factor influ-
ence at 7 to 35 % (Tick et al. 2016), 5 to 44 % (Colvert et al.
2015), 50 % (Sandin et al. 2014), and 55 % (Hallmayer et al.
2011). Huguet et al. (2016) reviewed ASD findings and pro-
posed a specific distribution of ASD risk factors: 49.8 % com-
mon inherited variants, 2.6 % rare inherited CNVs and SNVs,
6.6 % de novo SNVs, 2.9 % de novo CNVs, and 38.1 %
environmental risk factors. Huguet et al. (2016) considered
the de novo SNVs and CNVs to be environmental and thus
52.4 % of ASD had genetic causes, and 47.6 % had environ-
mental causes. Most importantly, gene-environment interac-
tions have been identified for ASD (LaSalle 2013; Jeste and
Geschwind 2014; Volk et al. 2014).
Summary BMultiple gene-few brain circuits^models are pre-
mature and lack explanatory coverage; thus, these models
cannot provide neurobiological validity for ASD.
The Bmultiple gene-few brain circuits^ models are prema-
ture and insufficiently explanatory because ASD risk gene
functions in networks are complex and not yet fully understood.
There are hundreds of ASD risk genes, and there is evidence for
gene-gene and gene-environment interaction in ASD etiology.
It is also possible that ASD polygenicity is so extreme as to
hinder specific causal inferences, and possible that ASD symp-
toms result from gene variants causing systemic processes that
are Bnot specific to ASD^ (Wen et al. 2016, p. 13).
Do ASD Diagnostic Criteria Have Construct
Validity?
The two core ASD diagnostic criteria of social impairment
and ASD RRBs and/or atypical sensory responsiveness would
have construct validity if these diagnostic symptoms were
invariantly expressed together or were expressed together
without additional nondiagnostic symptoms. Research to de-
termine the links between the ASD diagnostic criteria has
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taken different approaches. One approach documented the
separate expression of the two core ASD diagnostic symptoms
in affected individuals. Another research approach looked for
what causes ASD diagnostic social impairment and ASD
RRBs to uniquely occur together. A third research approach
investigated whether ASD diagnostic criteria occur in TD
children. A fourth approach looked for the comorbidity of
ASD diagnostic symptoms with symptoms of other psychiat-
ric and neurodevelopmental disorders.
Criteria Validity Research Approach 1: Do ASD
Diagnostic Symptoms Occur Independently in Affected
Individuals?
Kanner (1943, 1951) asserted that autism social withdrawal
always occurred with the obsessive desire for the preservation
of sameness. Although Kanner’s claim of an invariant bond
between these core symptoms provided construct validity for
the infantile autism diagnosis, subsequent research has not
supported Kanner’s claim. No invariant link between ASD
social impairment and ASD RRBs has been discovered
(Frazier et al. 2014; Harrop et al. 2013; Pina-Camacho et al.
2012; Shuster et al. 2014). Many who express ASD diagnostic
social impairment do not express the need for the preservation
of sameness or any of the RRBs (Brennan et al. 2015; Kim
et al. 2014; Kulage et al. 2014; Mandy et al. 2011; McPartland
et al. 2012; Ventola et al. 2006). For example, in comparing
toddler diagnostic instruments, Ventola et al. (2006) found that
when a diagnostic instrument required RRBs, a majority of the
children who had clinical autism diagnoses did not meet
DSM-IV-TR autistic disorder (AD) diagnostic criteria
(American Psychiatric Association 2000). However, all clini-
cally diagnosed children were correctly diagnosed with AD
when assessed by instruments that did not require the expres-
sion of RRBs (Ventola et al. 2006).
In a study of 256 children with DSM-IV-TR pervasive
developmental disorder-not otherwise specified (PDD-NOS),
Mandy et al. (2011) found that 97 % of those with PDD-NOS
expressed AD diagnostic social impairment, but only 3 %
expressed AD RRBs. Comparing DSM-IV-TR and DSM-5
diagnostic categories, McPartland et al. (2012) reported that
most individuals previously diagnosed with Asperger’s syn-
drome or PDD-NOS did not meet DSM-5 ASD diagnostic
criteria, but would meet DSM-5 criteria if the requirement
for RRBs was eliminated. Similarly, Kim et al. (2014) report-
ed that nearly all individuals with a prior diagnosis of AD,
Asperger’s disorder, or PDD-NOS diagnosis who did not meet
DSM-5 ASD criteria did express ASD social impairment, but
did not express two of the four RRBs and/or atypical
responsiveness.
Individuals who express ASD diagnostic social impairment
but no RRBs or one RRB are in diagnostic limbo (Happé et al.
2006; Hus et al. 2007; Lam et al. 2008; Mandy and Skuse
2008; Szatmari et al. 2006; Watt et al. 2008). These individ-
uals might meet criteria for the new DSM-5 social communi-
cation disorder (SCD) diagnosis (Smith et al. 2015). However,
Bishop (2014) claimed that the DSM-5 category of language
disorder was flawed, and Norbury (2014) warned that the
SCD diagnosis would confusingly overlap with the ASD di-
agnosis because many diagnosed with SCD express full ASD
social impairment and also express one of the two required
RRBs and/or atypical sensory responsiveness.
ASD Social Impairment and RRBs Form Independent Factors
ASD criteria have been shown to form independent factors
(Frazier et al. 2014). Frazier et al. (2014) reported a two-
factor model with one factor for each core ASD diagnostic
criterion. Similarly, Harstad et al. (2015) reported finding
one ASD social impairment factor and one RRBs factor.
Shuster et al. (2014) reviewed 36 factor analytic studies of
ASD symptoms and concluded that ASD social interaction
impairment formed one factor, while RRBs formed a separate
independent factor.
Separate factors for the ASD core criteria have been repli-
cated despite mixed evidence for the intercorrelations of ASD
symptoms. Although some researchers have reported positive
correlations between social impairment and RRBs (Frazier
et al. 2014; Lam et al. 2008; Szatmari et al. 2006; Watt et al.
2008), other researchers reported finding no or limited asso-
ciations between social impairment and the RRBs (Harrop
et al. 2013; Hus et al. 2007; Mandy and Skuse 2008; Veatch
et al. 2014).
Distinct Subgroups Have Been Identified Within ASD Social
Impairment
Wing and Gould (1979) reported finding three distinct types
of ASD social impairment—aloof, active-but-odd, and pas-
sive. More recently, Scheeren et al. (2012) identified two so-
cial impairment subgroups in higher functioning ASD, indi-
viduals with active-but-odd interaction, and individuals with
aloof social interaction. Corbett et al. (2014) reported two
ASD social-cortisol level groups: the ASD low social motiva-
tion group engaged in less social play and expressed higher
levels of cortisol in interaction, and the ASD moderate social
motivation group engaged in relatively more social play and
expressed lower levels of cortisol in interaction.
Pierce et al. (2015) reported finding two ASD social atten-
tion subgroups: 80 % of toddlers with ASD preferred to look
at dynamic social images, but 20 % of toddlers with ASD
strongly preferred to look at dynamic geometric images.
Pierce et al. (2015) noted that none of the children in compar-
ison groups, including Btoddlers with typical development,
language delay, and global developmental delay as well as
unaffected siblings of toddlers with ASD^ (p. 6), preferred
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to look at dynamic geometric images. Bishop et al. (2016)
reported finding two clusters of ASD social impairments.
One cluster included basic social communication deficits in
eye contact, facial expression, shared enjoyment, and gesture
that Bishop et al. (2016) identified as characterizing true core
ASD. These social skills were relatively more Bintact in …
children with severe intellectual disability, early trauma/ne-
glect, prenatal teratogenic exposure, (and) extreme prematuri-
ty^ (Bishop et al. 2016, p. 5). The other cluster of social
impairments included impaired quality of social reciprocity
and impaired social rapport that Bishop et al. (2016) stated
was more prevalent than the first cluster of social impairments
in non-ASD neurodevelopmental disorders.
Distinct Subgroups Have Been Identified Within the ASD
RRBs
Some factor analyses of the RRBs have reported multiple
subgroups (Esbensen et al. 2009; Mirenda et al. 2010;
Frazier et al. 2014). Leekam et al. (2011) noted an age strati-
fication in the RRBs where, Blower level RRBs are more
apparent in younger and more developmentally delayed cases,
and preoccupations, special interests, and obsessions more
often found in older and more able cases^ (p. 564). This de-
velopmental split in the RRBs has appeared as two clusters: a
younger motor cluster with stereotyped movements and repet-
itive manipulation of objects; and an older cognitive cluster
with compulsions, rituals, insistence on sameness, and
circumscribed interests (Bishop et al. 2013; Georgiades et al.
2010; Leekam et al. 2011).
Summary The independence of ASD symptoms in clinical
autism does not support the construct validity of an invariant
link between core ASD diagnostic symptoms.
Many who express ASD diagnostic social impairment do
not express two of the RRBs and/or atypical sensory respon-
siveness, and therefore, ASD does not have construct validity
based on an invariant link between the two core diagnostic
symptoms. Equally important, there is no adequate clinical
diagnosis for individuals who nearly meet all criteria for ASD.
Criteria Validity Research Approach 2: Do the Two Core
ASD Diagnostic Criteria Occur Together in the Absence
of Other Symptoms?
As reviewed in the section above, ASD social impairment and
ASD RRBs do not have an invariant link, and many individ-
uals exhibit ASD diagnostic social impairment but express
none or only one of the RRBs. Consequently, Happé et al.
(2006), Boucher (2011), Shuster et al. (2014), and Brunsdon
and Happé (2014) all raised the concern that no brain impair-
ment had been found that caused only the ASD social
impairment and ASD RRBs to occur together, and no theory
had explained why the core ASD diagnostic symptoms did
occur together. Boucher (2011) and Shuster et al. (2014) ar-
gued for studying core symptoms separately, and Waterhouse
(2013) recommended studying ASD social impairment alone.
Brunsdon and Happé (2014) argued that there was no uni-
tary basis for ASD diagnostic symptoms because each ASD
diagnostic symptom was linked to Bdifferent genes, neural
patterns and cognitive components that influence distinct be-
havioral symptoms^ (p. 27). The claim of different neural
patterns for each symptom is supported by the evidence
discussed above that each ASD diagnostic symptom has been
found with a different set of varied brain impairments (Harrop
et al. 2013; Hormozdiari et al. 2015; Jason et al. 2015; Pina-
Camacho et al. 2012; Shuster et al. 2014; Zilbovicius et al.
2013). However, existing evidence argues that ASD social
impairment and the RRBs are very unlikely to be generated
by separate genes in one individual. Although studies of TD
twins found social impairment and RRBs to be independently
heritable (Robinson et al. 2011; Ronald et al. 2011), this is not
true for syndromic ASD with FXS, RTT, TSC, the
RASopathies, the Shankopathies, FAS, or ASD with extreme
prematurity. In these and other cases of syndromic ASD, a
specific gene mutation or prenatal event appears to cause both
ASD social impairment and RRBs as well as other symptoms.
In addition, individual SNPs, such as those that disrupt the
Ras/MAPK pathway (Adviento et al. 2014), also appear to
cause both core diagnostic symptoms in idiopathic ASD.
Finally, where multiple risk genes combine to cause ASD, it
has not yet been determined that one gene or set of genes
yields social impairment while another gene or set of genes
yields the RRBs and/or atypical sensory responsivity (Jiang
et al. 2013; Lim et al. 2013; Murdoch and State 2013; Sanders
et al. 2015).
ASD diagnostic symptoms are expressed together because
ASD genetic and nongenetic risk factors cause brain impair-
ments that yield both ASD diagnostic symptoms (Chen et al.
2015; Ornoy et al. 2015) and at rates above chance (Happé
et al. 2006). However, ASD risk factors do not cause only
ASD social impairment and RRBs to be expressed together
at rates above chance. In fact, fewer than 5 % of individuals
with ASD have been found to express ASD diagnostic social
impairment and RRBs together without any non-ASD symp-
toms (Lundström et al. 2015b), and/or minor physical anom-
alies (MPAs) (Tammimies et al. 2015), and/or MCAs
(Timonen-Soivio et al. 2015). More than 95 % of individuals
with ASD express ASD diagnostic symptoms along with
ADHD, ID, epilepsy, language impairment, motor dysfunc-
tions, attention deficits, anxiety, varied medical conditions,
and many other symptoms (Coleman and Gillberg 2012;
Lundström et al. 2015b; Pine et al. 2008; Richards et al.
2015; Waterhouse 2013). Because the vast majority of those
diagnosed with ASD also express one or more non-ASD
symptoms, ASD lacks the construct validity that would be
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provided by diagnostic symptom co-expression in the absence
of other symptoms.
Counter to this, however, Rutter (2014) argued that Bthere
is a problem in defining autism on the basis of particular
features without considering a broader pattern^ (p. 55) of
non-ASD symptoms found with ASD. Rutter (2014) argued
that ADHD, ID, epilepsy, language impairment, and other
nondiagnostic symptoms provided ASDwith a validating pat-
tern of ASD-specific nondiagnostic symptoms. However, this
validating pattern of non-ASD symptoms is not one consistent
pattern, but instead, non-ASD symptoms vary widely from
one diagnosed individual to another. Moreover, these associ-
ated symptoms stand against the construct validity of a unique
co-expression of ASD symptoms. Most importantly, ADHD,
ID, epilepsy, and language impairment occurring with ASD
symptoms are linked to varied brain impairments that stand
against the biological validity of ASD (Gabis and Pomeroy
2014; Jeste and Geschwind 2014; Klusek et al. 2015; Peters
et al. 2013).
Summary Because nearly 100 % of those with ASD also
express non-ASD symptoms, there are too few instances of
the unique co-expression of just the two ASD core diagnostic
symptoms to provide construct validity for the ASD
diagnosis.
ASD core diagnostic symptoms occur alone together with-
out other nondiagnostic symptoms in vanishingly few individ-
uals. Consequently, there is insufficient coverage for ASD
construct validity based on unique ASD symptom co-expres-
sion. Some researchers have proposed to make ASD more
homogeneous by refining ASD diagnostic criteria (Bishop
et al. 2016; Sonuga-Barke 2016) and by developing more
sensitive ASD diagnostic screening instruments (Bone et al.
2016). However, it is unlikely that the many nondiagnostic
symptoms such as ADHD, ID, epilepsy, and language impair-
ment that occur with ASD that stem from varied ASD brain
impairments caused by varied ASD risk factors (Kida and
Kato 2015) will be eliminated by refinement of the ASD
criteria or refinement of ASD screening measures.
Criteria Validity Research Approach 3: Do ASD
Diagnostic Criteria Occur Independently in Typical
Children?
Many very young TD children express RRBs, including re-
stricted interests, repetitive motor behaviors, change resis-
tance, and/or atypical sensory responsiveness (Camarata
2014; Harrop et al. 2013; Van Hulle et al. 2012). In fact,
Harrop et al. (2013) noted that young TD children and young
children diagnosed with ASD express similar rates of RRBs.
However, RRBs disappear in typically developing children
after they Bserve the purpose of developmental mastery^
(Harrop et al. 2013, p. 3). Thus, RRBs in older children with
ASDmay be evidence for developmental delay or evidence of
atypical limits to development (Camarata 2014; Harrop et al.
2013). However, only extremely shy but otherwise typically
developing children show severe social withdrawal in that
they Brarely initiate social contacts with available playmates,
tend to withdraw from social interactions^ (Coplan et al. 2013,
p. 862).
Happé et al. (2006) found modest or weak correlations
between ASD social impairment symptoms and RRBs in typ-
ically developing 7- and 8-year-old twins. Posserud et al.
(2013) reported separate factors for social impairment and
RRBs in a sample of 10,220 typically developing
adolescents. Conversely, Constantino and Charman (2015)
concluded that ASD Bcharacteristic traits and symptoms…
are as highly inter-related in the general population as they
are in ASD syndromes^ (p. 7), and asserted that ASD traits
were continuous; therefore, any boundary between TD and
ASD was arbitrary.
Summary The independence of the two core ASD symptoms
in typical children stands against the construct validity of a
general invariant link of ASD diagnostic symptoms in TD.
RRBs are commonly expressed in young typically devel-
oping children (Harrop et al. 2013), but ASD social withdraw-
al is extremely rare in typical development (Coplan et al.
2013). These findings and TD twin study findings
(Robinson et al. 2011; Ronald et al. 2011) argue against a
general invariant coupling of ASD social impairment and
ASD RRBs in TD.
Criteria Validity Research Approach 4: Is ASD Comorbid
with Other Psychiatric Disorders?
The DSM-III nosology (American Psychiatric Association
1980) triggered an increase in the comorbidity of diagnoses
because DSM-III divided complex psychiatric phenotypes in-
to fixed diagnostic categories with specific required symp-
toms. As a result, often more than one diagnosis was needed
to cover the full range of an individual’s symptoms (Maj
2005).
Skokauskas and Frodl (2015) found moderately high levels
of comorbidity of ASD and bipolar disorder (BPD). Levy
et al. (2010) found that 39 % of those with ASD expressed
anxiety and mood disorder symptoms, compared with only
4 % of controls. Pine et al. (2008) reported that 57 % of
children with BPD, 38 % of children with major depressive
disorder (MDD), and 25 % of children with anxiety disorder
expressed ASD symptoms. Croen et al. (2015) reported that
54 % of adults with ASD were diagnosed with an additional
psychiatric disorder, including anxiety (29 %), BPD (11 %),
depression (26 %), SCZ (8 %), and OCD (8 %).
OCD and ASD symptoms have been reported to be comor-
bid in frequencies ranging from 1.5 to 81 % and OCD
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compulsions have parallels in ASD insistence on sameness
and ASD repetitive behaviors (Meier et al. 2015; Stone and
Chen 2015). Surprisingly, although OCD is often found with
increased gray matter volumes in the caudate nuclei (Meier
et al. 2015), the OCD-like insistence on sameness in ASD
without OCD has been linked to every subcortical region
except the caudate (Eisenberg et al. 2015).
Half of those diagnosed with SCZ have expressed ASD
diagnostic social impairment (Matsuo et al. 2015), and social
cognitive impairment was found to be the same in Asperger’s
disorder and SCZ (Lugnegård et al. 2013), as well as the same
in ASD and SCZ (Eack et al. 2013). Moreover, SCZ was
diagnosed in 2.4 % of those with ASD (Kohane et al. 2012).
Evidence also has indicated that if one parent was diagnosed
with SCZ, there was an increased risk for having a child with
ASD (Larsson et al. 2005).
Multiple complex developmental disorder (MCDD) is a
psychosis prodrome disorder leading to overt psychosis or
SCZ that is often found with ASD or PDD symptoms, as well
as with panic, explosive emotional behaviors, magical think-
ing, easy confusability, and paranoid preoccupations (Ad-
Dab’bagh and Greenfield 2001; de Bruin et al. 2007;
Kyriakopoulos et al. 2015; Sprong et al. 2008; Oranje et al.
2013; Ziermans et al. 2009). MCDD is not a DSM-5
diagnosis, and the brain basis of MCDD remains unknown.
Oranje et al. (2013) reported no deficits in P50 wave suppres-
sion and prepulse inhibition (PPI) of the startle reflex in
MCDD with ASD suggesting that there were no SCZ-like
sensory gating problems. Ziermans et al. (2009) also found
no abnormalities in brain gray matter or white matter in
MCDD with PDD.
Summary Comorbidity of psychiatric symptoms in ASD
stands against ASD construct validity.
The comorbidity of SCZ, BPD, MDD, OCD, MCDD, and
anxiety symptoms in ASD (along with symptoms of ID, epi-
lepsy, language impairment, motor dysfunctions, and others)
stands against the construct validity of the ASD diagnosis by
demonstrating that most complete ASD phenotypes are inad-
equately covered by the two core ASD diagnostic symptoms.
One likely contributor to such high ASD comorbidity is that
ASD shares risk genes with other disorders (Brandler and
Sebat 2015).
Do Shared Features Provide Construct Validity
for an ASD Spectrum?
An ASD spectrum of related disorders would have construct
validity if the spectrum had features common to all diagnosed
with ASD beyond simply the ASD diagnostic symptoms.
Researchers have looked for five types of unifying ASD fea-
tures. One line of research has looked for a consistent early
behavioral or biological predictor shared by all with ASD. A
second line of research has looked for a consistent develop-
mental course or life outcome for ASD. A third line of re-
search has looked for a single predictive recurrence risk for
possible future siblings of those with ASD. A fourth line of
research has looked for a consistent broader ASD phenotype
(BAP) in siblings and parents. Finally, a fifth line of research
has looked for valid subgroups within the ASD spectrum.
Feature Validity Research Approach 1: Is There
a Consistent Early ASD Predictor?
Yirmiya and Charman (2010) observed that little is known
about Bthe prodrome of ASDs^ (p. 450), and Reeb-
Sutherland and Fox (2015) noted that studies attempting to
predict which infant siblings would go on to develop ASD
Bhad little success reliably identifying behavioral markers dur-
ing infancy that predict the later manifestation of ASD^ (p.
390). Volkmar and Reichow (2014) suggested that one diffi-
culty for early ASD diagnosis was Bthe broad range of severity
and associated communicative and cognitive disability^ (p.
11). Barbaro and Dissanayake (2013) reported that at
12months, deficits in pointing, waving, imitation, eye contact,
and name response were significant markers for an ASD di-
agnosis, but that by 24 months, only deficits in eye contact
remained a reliable index of ASD.
Elsabbagh and Johnson (2016) reported that social impair-
ment was not a key early characteristic of ASD, which instead
included five features: (1) head lag when an infant is pulled up
to sitting, (2) atypically high sensitivity to sensory experience,
(3) trouble with consonants in earliest language, (4) atypically
slower ability to shift away attention, and (5) general atypical-
ly lower level of activity. Similarly, in a study of young sib-
lings of individuals with ASD, Sutera et al. (2007) reported
that ASD diagnostic social and communicative skills were not
predictive but that motor skills were predictive of later diag-
nostic outcome.
A consensus panel of ASD researchers reported there was
no Bsingle behavioral sign or a single developmental trajectory
that is predictive of all diagnoses of ASD^ (Zwaigenbaum
et al. 2015, p. S37), and the panel asserted that ASD hetero-
geneity made it unlikely that any defining early ASD behav-
ioral marker will ever be found.
As discussed in the first section of this paper, a dominant
theory has argued that ASD results from early brain over-
growth with later impaired brain connectivity (Solso et al.
2015). Consequently, early brain overgrowth has been pro-
posed as the primary biomarker for ASD (Anderson 2013;
Ecker et al. 2015; Shen et al. 2013). However, as previously
outlined, early brain overgrowth is rare in ASD. The meta-
analysis of Sacco et al. (2015) found macrocephaly in less
than 6 % of ASD, and also, as reported earlier, Chaste et al.
(2013), Raznahan et al. (2013), and Cederlund et al. (2014)
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found no evidence that ASD was characterized by early brain
overgrowth.
Jones and Klin (2013) argued that early decline in eye
fixation would be the best single biomarker of ASD. The
researchers claimed this biomarker reflected that a disrupted
reward-based interactional eye fixation regulatory system was
the core ASD brain impairment (Klin et al. 2015). Reeb-
Sutherland and Fox (2015), however, suggested that atypical
eyeblink conditioning was a possible single ASD biomarker,
and Jeste et al. (2015) proposed that EEG patterns might be a
possible biomarker for ASD.
Small and Pelphrey (2015) proposed, BInnate olfactory be-
haviors may provide a link between early emerging sensory
motor behaviors and the social deficits that characterize ASD^
(p. R675). Rozenkrantz et al. (2015) reported that longer time
sniffing an unpleasant odor was 81 % accurate in differentiat-
ing children with ASD from typically developing children,
and Rozenkrantz et al. (2015) and Small and Pelphrey
(2015) suggested that a sniff test could serve as an effective
single biomarker for ASD.
However, Varcin and Nelson (2016) argued that BThe het-
erogeneity inherent to ASD necessitates… sets of markers,
rather than a single marker^ (p. 127). Glatt et al. (2012) iden-
tified a blood-based gene expression profile of 48 genes that
reliably identified young children with ASD. Taylor et al.
(2014) and Ruggeri et al. (2014) proposed large panels of
biomarkers to include markers such as head circumference
above the 97th percenti le, long-range functional
hypoconnectivity and short-range hyperconnectivity, ERP-
measured speed of response to human faces, elevated blood
serotonin (5-HT) levels, and autoantibodies against a range of
brain antigens localized in GABAergic neurons. However,
Varcin and Nelson (2016) concluded that BBiomarkers with
sufficient sensitivity and specificity for clinical application are
yet to be identified in ASD^ (p. 124).
Summary There is no consistent early behavioral or brain
predictor for ASD; thus, these findings do not support con-
struct validity for an ASD spectrum.
Ideally, clinicians use early symptoms to determine prog-
nosis and assign individuals to treatment. However, ASD re-
search has discovered many varied early behaviors and varied
brain markers, and no consistent predictor pattern has been
found. Panels of multiple biomarkers have been proposed to
help net ASD heterogeneity.
Feature Validity Research Approach 2: Is There One ASD
Developmental Course?
Understanding the developmental course of ASD is crucially
important for managing life care and planning treatment.
However, ASD occurs with many varied developmental paths
(Fountain et al. 2012; Lord et al. 2015), and there is no one
consistent life outcome (Fein et al. 2013; Helles et al. 2015;
Steinhausen et al. 2016). Variation in ASD developmental
course has ranged from typical development in infancy that
becomes atypical in early childhood, to marked infant impair-
ment in social and cognitive skills that changes to become
optimal adaptive functioning in adulthood (Anderson et al.
2014; Fein et al. 2013; Fountain et al. 2012; Helles et al.
2015; Howlin et al. 2013; Levy and Perry 2011; Lord et al.
2015; Yirmiya and Charman 2010).
Predictors of ASD Outcome Are Varied
Although Howlin et al. (2013) reported that ASD childhood
IQ was not a predictor of adult outcome in their sample, none-
theless, many researchers have found that IQ was a good pre-
dictor, or even the best predictor of outcome in ASD (Hedvall
et al. 2014; Jones et al. 2014; Magiati et al. 2014). Billstedt
et al. (2007) reported that childhood IQ and social
communication before age 5 were the strongest predictors of
adult outcome in ASD. Anderson et al. (2014) reported that
25 % of higher IQ children with ASD experienced notably
improved functioning at age 19, but that lower functioning
children with ASD did not have comparable improvement.
Rates of Recovery from ASD Are Varied
Howlin et al. (2013) determined that long-term follow-up
studies indicated that a majority of adults with ASD had
not recovered. Steinhausen et al. (2016) conducted a
meta-analysis of ASD adolescent and adult outcome stud-
ies and determined that 19.7 % had a good outcome,
31.1 % had a fair outcome, but 47.7 % of those with
ASD had a poor outcome. Fein et al. (2013) reported that
good or optimal outcomes for ASD ranged widely, from
about 1 % to nearly 50 %.
Blumberg et al. (2015) reported that 13 % of 1607 individ-
uals diagnosed with ASD in childhood no longer met criteria
for ASD: 9 % had been initially misdiagnosed and 4 % Blost^
their ASD due to treatment or maturation. Helles et al. (2015)
found that 24 % of individuals diagnosed initially with
Asperger’s disorder no longer met criteria for any develop-
mental disorder. However, developmental changes are com-
plex. For example, Olsson et al. (2015) found that a majority
of preschool children who were clinically judged to be recov-
ered from an early ASD diagnosis were rediagnosed with
ASD or other neurodevelopmental disorders just 4 years later.
Fein et al. (2013) recruited 34 adults who had been diagnosed
with ASD as children, but whose behavior was now compa-
rable to that of typical adults. Magiati et al. (2014) reviewed
18 ASD adult outcome studies and reported that 50 % of
adults with ASD were able to live independently.
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Summary Existing evidence for varied developmental
courses and life outcomes does not provide construct validity
for an ASD spectrum.
The findings for outcome and developmental trajectories
suggest that the ASD diagnosis does not identify a consistent
specifiable developmental course or life outcome.
Feature Validity Research Approach 3: Is There a Unitary
ASD Recurrence Risk?
The assumption that ASD was a unitary entity led to efforts to
establish a single recurrence risk rate for ASD. Recurrence
risk is the likelihood that a second child with ASD would be
born in a family where a child has already been diagnosed
with ASD. No consistent recurrence risk for ASD has been
established, and rates have varied from 6 to 19 % (Grønborg
et al. 2013; Ozonoff et al. 2011; Ronemus et al. 2014; Rosti
et al. 2014; Werling and Geschwind 2013).
However, Matsunami et al. (2014) asserted that no sin-
gle inheritance model for ASD could be correct, because
many varied forms of genetic transmission occur with
ASD, and Ronemus et al. (2014) noted that ASD genetic
transmission recurrence risk must vary for families with
one child with ASD (simplex) and families with more
than one child with ASD (multiplex). An example of var-
ied genetic transmission was reported by Jiang et al.
(2013), who found multiple varied ASD inheritance pat-
terns in just 16 families: 12 rare X-linked deleterious var-
iants, 7 rare deleterious autosomal-dominant mutations,
13 deleterious missense mutations, and 15 de novo dele-
terious mutations. Another problem for recurrence rate
determination was discovered by Grønborg et al. (2013),
who found increased ASD risk in maternal half-siblings,
indicating that environmental factors unique to the
mother’s pregnancy history may contribute to ASD recur-
rence risk.
Summary Recurrence risk findings do not provide construct
validity for an ASD spectrum.
Researchers have identified many varied ASD genetic risk
factors with varied transmission patterns, and because there
are also many varied ASD environmental risk factors, no sin-
gle recurrence risk can ever be determined for the ASD
diagnosis.
Feature Validity Research Approach 4: Is There
a Consistent Broader Autism Phenotype (BAP)?
The assumption that ASD was a unitary disorder led re-
searchers to look for a unitary BAP in families of individuals
diagnosed with ASD. The BAP is theorized to be the expres-
sion of attenuated ASD symptoms in family members.
However, BAP symptoms have been found to be as
heterogeneous as ASD symptoms and have included cogni-
tive, language, and social skill impairments, as well as atten-
uated and nonattenuated psychiatric symptoms (Sucksmith
et al. 2011).
Do Siblings of Individuals with ASD Express Varied BAP
Symptoms?
Ozonoff et al. (2014) reported that 28 % of siblings of
individuals with ASD expressed a BAP consisting of mild
social impairment. However, Sucksmith et al. (2011) re-
ported that BAP symptoms in siblings were quite varied
and included impaired social responsiveness, impaired
mental state recognition, impaired basic emotion
recognition, impaired face processing, language delay,
pragmatic language impairment, atypical eye gaze
patterns, and impaired joint attention. Szatmari et al.
(2016) concluded that the siblings of children with ASD
express a significant Bvariability in terms of both type and
severity^ (p. 183) of BAP symptoms.
Taylor et al. (2015) reported that in families with two or
more children with ASD, the undiagnosed siblings had signif-
icantly greater social impairment and pragmatic language im-
pairment than did undiagnosed siblings in families where only
one child was diagnosed with ASD.
Do Parents of Individuals with ASD Express Varied BAP
Symptoms?
Cruz et al. (2013) reviewed studies of BAP in parents of
individuals with ASD and found widely varied BAP
symptoms in parents, including pragmatic language
impairment, lack of friends, difficulties in planning,
impaired working memory, and impaired detection of
emotions in face expressions. Cruz et al. (2013) also not-
ed a great variation in BAP symptom prevalence, ranging
from no parent deficits in skills such as reading and spell-
ing to more than 40 % of parents expressing some form of
pragmatic language deficit.
Losh et al. (2008) examined specific features of BAP
in parents, including overconscientiousness, rigidity,
aloofness, anxiety, hypersensitivity, tactlessness, pragmat-
ic language deficits, speech deficits, and lack of friend-
ships, and discovered four general deficit trait factors:
language, rigidity, anxiety, and sociability. Losh et al.
(2008) reported a high prevalence of BAP symptoms in
their samples. In the sample of parents who had more than
one child diagnosed with ASD, 92 % of parents expressed
at least one BAP symptom, and in the sample of parents
with a single child diagnosed with ASD, 66 % of parents
expressed at least one BAP symptom.
Losh et al. (2008) reported that in families with more than
one child diagnosed with ASD, parents were four times as
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likely to express two or more of the deficit traits than parents
with a single child diagnosed with ASD. Similarly, Bernier
et al. (2012) reported that in families where more than one
family member was diagnosed with ASD, more undiagnosed
family members expressed BAP symptoms. Woodbury-Smith
et al. (2015) looked for a genetic link between parents’ BAP
and presence of specific CNVs in their children diagnosed
with ASD, but could only find, Ba small number of CNVs
transmitted from BAP parents to ASD offspring^ (p. 196).
Summary Varied BAP findings provide no construct validity
for an ASD spectrum.
Pisula and Ziegart-Sadowska (2015) reviewed sibling stud-
ies and concluded that evidence was, Binsufficient to formu-
late final conclusions regarding BAP characteristics in sib-
lings of people with ASD^ (p. 13250). Cruz et al. (2013)
similarly concluded that findings for BAP in parents were so
varied that Bfurther studies should be conducted before there is
a definition of which traits are undoubtedly part of the group
of BAP characteristics^ (p. 261). It is likely that widely varied
brain dysfunctions in family members with BAP result in
varied constellations of social, language, cognitive, and psy-
chiatric symptoms.
Feature Validity Research Approach 5: Are There Valid
ASD Spectrum Subgroups?
Researchers have proposed that ASD includes biologically
valid subgroups (Aldinger et al. 2015; Brandler and Sebat
2015; Ellegood et al. 2015; Georgiades et al. 2013; Williams
et al. 2014; Whitehouse and Stanley 2013; Williams and
Bowler 2014). Williams et al. (2014) predicted that ASD
would eventually become a set of biologically valid subgroups
defined Bby genetic and/or neurological…findings^ (p. 339),
and Brandler and Sebat (2015) predicted that ASD would
naturally disband into valid Bquanta of separate genetic
disorders^ (p. 502).
Researchers have subtyped many aspects of ASD. There
has been ASD gender subgrouping (Halladay et al. 2015;
Ypma et al. 2016), ASD brain feature subgrouping (Piras
et al. 2014; Hahamy et al. 2015), ASD behavior subgrouping
(Chaste et al. 2015; Kim et al. 2016; Veatch et al. 2014), ASD
developmental course subgrouping (Fountain et al. 2012;
Lord et al. 2015), ASD behavior and brain feature
subgrouping (Lombardo et al. 2015), ASD MPAs
subgrouping (Tammimies et al. 2015), ASD MCAs
subgrouping (Timonen-Soivio et al. 2015), and ASD risk gene
variant subgrouping (Hormozdiari et al. 2015; Krumm et al.
2014; Noh et al. 2013).
Males and females are valid biological subgroups. Males
with ASD show more aggression and repetitive behaviors,
while females with ASD express more mood disorders, and
that females with ASD have greater cognitive impairment
than males with ASD (Jeste and Geschwind 2014). There is
a sex ratio of four or five males for every female with ASD
(Halladay et al. 2015; Jeste and Geschwind 2014; Romano
et al. 2016; Ypma et al. 2016). Romano et al. (2016)
asserted that male genetic variants make them more vulner-
able to ASD risk factors than are females. Jeste and
Geschwind (2014) proposed that a possible reduced female
vulnerability, termed the female protective effect (FPE),
arises from genes in females that are found on the sex
chromosomes , and the effec ts of sex hormones
themselves. Halladay et al. (2015) noted support for the
FPE in that females with ASD carry a higher number of
dnCNVs and de novo loss of function point mutations than
do males with ASD.
However, the sex ratio of males and females in ASD has
not been adequately explained by either increased male vul-
nerability or a special female protective factor (Halladay et al.
2015; Ypma et al. 2016). For example, at the lowest level of
ID, the male-female ASD sex ratio is 1:1. In addition, dif-
ferent etiologies have different sex ratios. Syndromic ASD
with RTT includes only females, and syndromic ASD with
FXS includes only males. Taking ASD apart by etiologies
will likely reveal that the current overall ASD sex ratio is
composed of many different separate sex ratios that vary by
etiology, sex chromosome gene effects, and sex hormone
effects.
Tammimies et al. (2015) divided children diagnosed with
ASD into three groups: those with many MPAs, those with
few MPAs, and those with some MPAs. Children with few
MPAs had fewer molecular diagnoses than the children with
many MPAs (Tammimies et al. 2015). However, there was
genetic heterogeneity in each of the three ASD MPA sub-
groups, including varied de novo mutations and other varied
molecular diagnoses (Tammimies et al. 2015).
Similarly, Chaste et al. (2015) found that subgrouping ASD
by distinct phenotypes did not result in finding sets of genetic
variants that were unique to distinct clinical phenotypes. In
fact, fewer and greater numbers of overlapping genetic vari-
ants were reported across the ASD phenotypic groups. Chaste
et al. (2015) nonetheless argued that clinical phenotypes must
have some Bpower for discovering genetic associations^ (p.
781).
Summary ASD subgroups have been insufficiently homoge-
neous to provide construct validity for an ASD spectrum.
Despite many efforts to form valid subgroups of ASD, no
ASD subgroups have become standard, and noASD subgroup
has yet achieved adequate internal homogeneity (Chen et al.
2015). Thus, to date, ASD has not been subdivided into valid
subgroups that together would provide construct validity for
the ASD spectrum. Males and females are valid biological
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subgroups, but the sex ratio of males and females in ASD has
not been adequately explained, and different ASD etiologies
have different sex ratios.
Conclusion: ASD Lacks Neurobiological
and Construct Validity—What Should Be Done?
Table 1 summarizes the 14 groups of findings reviewed in this
paper that together argue that ASD lacks neurobiological and
construct validity. No unitary ASD brain impairment or repli-
cated unitary model of ASD brain impairment exists. ASD
core diagnostic symptoms are not uniquely linked and are
only very rarely expressed without nondiagnostic symptoms.
ASD has no reliable early predictor, no unitary developmental
course, no unitary life outcome, no unitary recurrence risk, no
unitary pattern of BAP features, and no standard homoge-
neous subgroups.
In sum, these findings suggest that neurodevelopmental
social impairment exists in varied forms with varied etiologies
and varied pathophysiologies, but the ASD diagnostic criteria
do not identify a valid entity. These findings argue that a shift
away from studying ASD-defined samples is warranted.
However, even though ASD lacks neurobiological and con-
struct validity, ASD is supported by the powerful existential
validity of wide, and perhaps increasing, clinical coverage. In
1989, Ritvo et al. reported that 4 in 10,000 were diagnosed
with autism (Ritvo et al. 1989). Now, 1 in 68 children are
diagnosed with ASD (Blumberg et al. 2013; Braun et al.
2015; Centers for Disease Control and Prevention 2012;
Christensen et al. 2015; Christensen 2016; Lundström et al.
2015a; Hansen et al. 2015; Kim et al. 2011; Kim 2014). This
wide coverage has helped to sustain the belief that ASD is a
unitary entity, but coverage cannot compensate or substitute
for missing neurobiological and construct validity.
In fact, despite its wide coverage, ASD has two coverage
problems. ASD is underinclusive because its coverage ex-
cludes those with ASD diagnostic social impairment who do
not fully meet the criteria for RRBs and/or atypical sensory
responsiveness. ASD is overinclusive because some of the
increase in ASD coverage has come from diagnostic substitu-
tion (Navon and Eyal 2016) or even, possibly, the force of
social exchange (Liu and Bearman 2015). Polyak et al.
(2015) reported that in the USA between 2000 and 2010, even
though the proportion of total diagnoses did not change, ASD
diagnoses increased 331 %, while ID decreased 31 %, emo-
tional disturbance decreased 22 %, and learning disability
decreased 19 %. Polyak et al. (2015) concluded Bdiagnostic
recategorization toward autism is occurring, potentially con-
founding estimates of autism prevalence^ (p. 4), and the re-
searchers asserted that diagnostic substitution revealed that
developmental diagnoses were fungible.
Table 1 Summary of varying, inconsistent, and unresolved findings for
studies of ASD brain impairments, ASD symptoms, and ASD spectrum
features
Research questions Answer Research study findings
ASD brain research has not provided evidence for the neurobiological
validity of ASD
Are there any consistent global
or regional brain structures
implicated in ASD?
No ASD global and regional brain
structure findings have been
varied and conflicting.
Have any theories of a unitary
ASD brain impairment been
replicated to become
standard?





symptoms linked to specific
brain impairments?
No Each ASD diagnostic
symptom and nondiagnostic
symptom has been found
with varied brain
impairments.
Is there a consistent unique
ASD brain basis for
syndromic ASD?
No Syndromic ASD has been
found with a wide range of
brain impairments caused
by risk factors for the
associated syndromes.
Do a set of ASD risk genes
cause impairment in just a
few related brain circuits?
No Multiple gene-few brain
circuits models are
premature and have not
addressed environmental
causes for ASD or variant
ASD brain impairments.
ASD symptom research has not provided evidence for the construct
validity of ASD diagnostic symptoms
Do ASD diagnostic symptoms
occur together in isolation?
No ASD diagnostic symptoms
have occurred with non-
ASD symptoms in 96 % of
individuals diagnosed with
ASD.
Do ASD diagnostic symptoms
invariantly occur together in
clinical autism?
No ASD social impairment has
frequently occurred in
individuals with clinical




Do ASD diagnostic symptoms
occur together in typically
developing children?
No Most typical children have
expressed RRBs in early
childhood, but ASD social
impairment is quite rare in
typically developing
children.
Is the ASD diagnosis found
with comorbid psychiatric
symptoms and disorders?
Yes ASD has been shown to share
symptoms with many
psychiatric diagnoses.
ASD feature research has not provided evidence for the construct validity
of the ASD spectrum
Is there any consistent early
behavioral feature or brain
marker that predicts an ASD
diagnosis?
No There is no consistent early
behavioral or brain
predictor for an ASD
diagnosis.
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Proposals for Future Research: Disband the ASD
Diagnosis, Study Individual Variation, and Revise
Instruments and Health Records
Disband the ASD Diagnosis in Research
ASD should be disbanded in research because it lacks validity,
and finding effective medical treatments requires the analysis
of individual variation in valid pathophysiological mecha-
nisms linked to specific risk factors in complete neuro-
developmental phenotypes (Kennedy et al. 2015; London
2014; Volkmar and McPartland 2015; Waterhouse and
Gillberg 2014). Because the ASD diagnosis is defined by just
two symptoms from an individual’s complete set of symp-
toms, an ASD-defined sample is widely over-inclusive, cap-
turingmany different Blifelong conditions that can arise from a
complex combination of multiple genetic and environmental
factors^ (Dawson 2016, para. 1), in which Bthe genetic archi-
tecture of ASD seems to be different from one individual to
another^ (Huguet et al. 2016, p. 118), and there are many
individually varied Bconnections between brain and behavior^
(Kennedy et al. 2015, p. 81). In sum, the heterogeneity of risk
factors, brain impairments, and non-diagnostic symptoms in
an ASD-defined sample blocks valid scientific inference.
Study Individual Variation in Brain Impairments
in Neurodevelopmental Disorders
There is no catalog of brain impairments for neuro-
developmental disorders because much past research was
based on the belief that each neurodevelopmental disorder
had its own specific brain impairment (Bourgeron 2015a).
Jeste and Geschwind (2014) highlighted the need for a catalog
of brain impairments in genetic research by inserting a ques-
tion mark where (ASD) brain impairments should have been
listed (Jeste and Geschwind 2014, Fig. 1, p. 75). Individual
variation in brain impairments reflects variation in risk factors,
and as argued for RDoC, pathophysiology variation is not
aligned with diagnostic categories but is a focus for specific
medical treatment.
Revise Instruments and Health Records
for Neurodevelopmental Disorders
Disbanding the ASD diagnosis will require new screening, eval-
uations, and health records for all neurodevelopmental disorders
to include social impairment and RRBs and sensory atypical
responsivity independent of the ASD diagnosis. Many forms
of electronic health records (EHRs) have been outlined
(Castillo et al. 2015; McCoy et al. 2015; Simon et al. 2014).
Gillberg (2010) proposed BEarly Symptomatic Syndromes
Eliciting Neurodevelopmental Clinical Examinations^ or
ESSENCE, to include early appearing difficulties in general
development, communication and language, social interrelated-
ness, motor coordination, attention, activity, behavior, mood,
and/or sleep. ESSENCE disorders include ASD, ADHD, ID,
BPD, oppositional defiant disorder (ODD), specific language
impairment (SLI), learning disabilities (LD), nonverbal learn-
ing disabilities (NVLD), tic disorders, behavioral phenotype
syndromes, rare epilepsy syndromes, and reactive attachment
disorder. Gillberg (2010) found that comorbidity resulted in
most children having two or more diagnoses. Empirical support
for ESSENCE (Bourgeron 2015b; Hatakenaka et al. 2016) has
demonstrated that it effectively documents the variation and
complexity of neurodevelopmental disorder symptoms.
London (2014) similarly recommended that research
should study DSM-5 neurodevelopmental disorders as a
whole, but proposed a multiaxial model that would allow for
the identification of specific symptoms such as sensory
overresponsiveness and ID, allow for possible etiologic
factors such as genetic findings or infection during
pregnancy, allow for functional assessment, and also allow
for treatment outcome history. Most importantly, London
(2014) noted that this reformulated nosology would direct
researchers and clinicians to attend to an individual’s specific
symptoms and not force researchers to assign a categorical
diagnosis. Instead an inventory of individual symptoms and
risk factors would provide a template suitable for clinical use
in lieu of a diagnostic category.
Drawbacks and Benefits of Disbanding ASD
in Research
Disbanding ASD in research is likely to be reductive and
uncomfortable. Most painfully, many existing ASD group
Table 1 (continued)
Research questions Answer Research study findings
Is there a consistent
developmental course or life
outcome for ASD?
No ASD is found with varied
developmental courses and
varied life outcomes.
Is there a single recurrence risk
for ASD?
No ASD does not and cannot have
a single recurrence risk rate
because there are so many
different forms of genetic
transmission and because so
many environmental risk
factors cause ASD.
Is there a consistent ASD
broader autism phenotype
(BAP)?
No BAP symptoms in siblings and
parents of children with
ASD have been found to
vary widely.
Is there any set of valid ASD
subgroups?
No Existing ASD subgroups have
shown a lack internal
homogeneity and have not
been adequately replicated.
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findings and ASD theories will be irrelevant for future
transdiagnostic studies, and future studies will likely be based
on varied grouping factors, making study findings less compa-
rable. There will also likely be conflicting interests as clinicians
continue to use DSM-5 ASD, while researchers develop new
types of studies that aggregate multiple neurodevelopmental
diagnoses. However, Zhao and Castellanos (2016) argued that
many large sample studies of psychiatric diagnoses have been
unproductive exactly because they studied traditional DSM
diagnoses. Zhao and Castellanos (2016) argued that
BNeuropsychiatric disorders are frequently transdiagnostic with
distinct subtypes likely among all disorders^ (p. 432); therefore,
large-scale imaging and genetics studies should benefit from
exploring multiple neurodevelopmental diagnoses together.
Most importantly, Lilienfeld and Treadway (2016) noted
that although DSM-5 diagnoses have captured much of indi-
viduals’ impairments, RDoC research is likely to yield
Bstratified medicine, in which interventions are tailored to in-
dividuals within well-defined subgroups^ (p. 447), something
that should be the central focus for all future research on
neurodevelopmental disorders.
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